188 related articles for article (PubMed ID: 28799830)
1. Effects of MicroRNA-27a on Myogenin Expression and Akt/FoxO1 Signal Pathway during Porcine Myoblast Differentiation.
Zhang S; Chen X; Huang Z; Chen D; Yu B; He J; Zheng P; Yu J; Luo J; Luo Y; Chen H
Anim Biotechnol; 2018 Jul; 29(3):183-189. PubMed ID: 28799830
[TBL] [Abstract][Full Text] [Related]
2. Leucine promotes differentiation of porcine myoblasts through the protein kinase B (Akt)/Forkhead box O1 signalling pathway.
Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; Luo J; He J; Zheng P; Yu J
Br J Nutr; 2018 Apr; 119(7):727-733. PubMed ID: 29569540
[TBL] [Abstract][Full Text] [Related]
3. Leucine promotes porcine myofibre type transformation from fast-twitch to slow-twitch through the protein kinase B (Akt)/forkhead box 1 signalling pathway and microRNA-27a.
Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; He J; Luo J; Zheng P; Yu J; Luo Y
Br J Nutr; 2019 Jan; 121(1):1-8. PubMed ID: 30449288
[TBL] [Abstract][Full Text] [Related]
4. miR-16 controls myoblast proliferation and apoptosis through directly suppressing Bcl2 and FOXO1 activities.
Jia X; Ouyang H; Abdalla BA; Xu H; Nie Q; Zhang X
Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):674-684. PubMed ID: 28258011
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNA-27a in myoblast differentiation.
Chen X; Huang Z; Chen D; Yang T; Liu G
Cell Biol Int; 2014 Feb; 38(2):266-71. PubMed ID: 24123794
[TBL] [Abstract][Full Text] [Related]
6. [Over-expression of FoxO1 inhibits the differentiation of porcine skeletal muscle myoblast].
Yuan Y; Shi X; Liu Y; Yang G
Sheng Wu Gong Cheng Xue Bao; 2010 Dec; 26(12):1668-73. PubMed ID: 21387829
[TBL] [Abstract][Full Text] [Related]
7. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
Xu H; Zhu J; Hu C; Song H; Li Y
J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy.
Wang B; Zhang C; Zhang A; Cai H; Price SR; Wang XH
J Am Soc Nephrol; 2017 Sep; 28(9):2631-2640. PubMed ID: 28400445
[TBL] [Abstract][Full Text] [Related]
10. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27a promotes porcine myoblast proliferation by downregulating myostatin expression.
Yang T; Chen XL; Huang ZQ; Wen WX; Xu M; Chen DW; Yu B; He J; Luo JQ; Yu J; Mao XB; Zheng P
Animal; 2014 Nov; 8(11):1867-72. PubMed ID: 25007254
[TBL] [Abstract][Full Text] [Related]
12. miR-483 inhibits bovine myoblast cell proliferation and differentiation via IGF1/PI3K/AKT signal pathway.
Song C; Yang Z; Dong D; Xu J; Wang J; Li H; Huang Y; Lan X; Lei C; Ma Y; Chen H
J Cell Physiol; 2019 Jun; 234(6):9839-9848. PubMed ID: 30422322
[TBL] [Abstract][Full Text] [Related]
13. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
14. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
[TBL] [Abstract][Full Text] [Related]
15. Bta-miR-885 promotes proliferation and inhibits differentiation of myoblasts by targeting MyoD1.
Elsaeid Elnour I; Dong D; Wang X; Zhansaya T; Khan R; Jian W; Jie C; Chen H
J Cell Physiol; 2020 Oct; 235(10):6625-6636. PubMed ID: 31985035
[TBL] [Abstract][Full Text] [Related]
16. The Inhibition on
Huang W; Guo L; Zhao M; Zhang D; Xu H; Nie Q
Cells; 2019 Jun; 8(7):. PubMed ID: 31261950
[TBL] [Abstract][Full Text] [Related]
17. Enhanced alleviation of insulin resistance via the IRS-1/Akt/FOXO1 pathway by combining quercetin and EGCG and involving miR-27a-3p and miR-96-5p.
Liu H; Guan H; Tan X; Jiang Y; Li F; Sun-Waterhouse D; Li D
Free Radic Biol Med; 2022 Mar; 181():105-117. PubMed ID: 35124182
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 promotes the differentiation of bovine skeletal muscle satellite cells by suppressing Sirt1/FoxO1.
Xu X; Ji S; Li W; Yi B; Li H; Zhang H; Ma W
Cell Mol Biol Lett; 2017; 22():10. PubMed ID: 28652859
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
